Drugs for Arthritis Flashcards

1
Q

types of arthritis

A

OA
RA
psoriatic
gout
ankylosing spondylitis
inflammation/pain/stiffness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

OA characteristics

A

degenerative to articular cartilage
WB joints
middle age
pain less than 30 min in morning
bone spurs
reduced ROM
cartilage breakdown
inflammation localized
pain worse w activity
no systemic symptoms
manage w acetaminophen, NSAIDs, PT, exercise, weight management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

RA characteristics

A

autoimmune, body attack joints
symmetrical
middle age
morning pain for hours
joints swollen/warm
joint deformity
systemic inflammation
worse after inactivity
fatigue/fever/weight loss
DMARDs, NSAIDs, corticosteroids
antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

main drugs to manage OA

A

analgesics
joint protection/restoration with hyaluronic acid and chondroitin sulfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

acetaminophen clinical use

A

first line treatment for OA pain relief

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

acetaminophen MOA

A

reduce PG production in brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

acetaminophen side effects

A

nausea/vomiting
lose of appetite
allergic rxn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

acetaminophen toxicity

A

liver toxicity with overuse due to toxic intermediate not being cleared fast enough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

NSAIDs commonly used for OA

A

ibuprofen/advil
Naproxen/aleve
Celecoxib/celebrex
diclofenac/voltaren, solaraze
meloxicam/mobic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

NSAIDs MOA

A

COX NZ inhibitor preventing PG synthesis mediating inflammation and pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

NSAIDs side effects

A

GI: ulcer, bleeding, heart burn, stomach upset
CV: increased risk of heart attack/stroke, prolonged bleeding
renal: renal failure/fluid retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

hyaluronic acid MOA

A

similar to synovial lubricant fluid
injected into joint to act as lubricant and shock absorber

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

hyaluronic acid side effects

A

pain at injection site
joint stiffness
headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

chondoitin sulfate MOA

A

building block of cartilage, prevent breakdown of cartilage and stimulate its repair, anti inflammatory properties
improve synovial fluid consistency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

chondroitin sulfate side effects

A

stomach pain
nausea
diarrhea
constipation
headache
swelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PT considerations for those taking analgesics

A

med schedule: time for optimal pain relief, be cautious of overdoing activity
monitor for overuse: overdoing activity causing strains
avoid overdosing
check side effects: avoid strenuous activity after taking hyaluronic for a few days
ask pt’s feedback on actvity

17
Q

pro-inflammatory cytokines of RA

A

interleukin-1 IL-1
tumor necrosis factor -a
TNF-a

17
Q

RA pathogenesis

A

cytokines are activated by immune response, T cells activated which make B cells active to produce antibodies resulting in bone removal by autoimmune response
activated T cells and macrophages promote inflammation

18
Q

RA treatment options

A

NSAIDs
glucocorticoids used sparingly
DMARDs: disease modifying anti rheumatic drugs

19
Q

DMARDs traditional vs targeted

A

traditional: restrict immune system broadly
targeted: block precise pathways inside immune cells
both inhibit RA autoimmune response

20
Q

hydroxychloroquine

A

immunomodulation for RA

21
Q

methotrexate

A

for RA
inhibit dihydrofolate reductase enzyme to reduce nucleotide synthesis

22
Q

lefunomide

A

inhibit pyrimidine synthesis
for RA

23
Q

biologic DMARDs for RA: TNF a blockers

A

etanercept
inflicimab
adalimumab
certolizumab
golimumab
monoclonal antibodies -mabs

24
Q

DMARD TNF-a suffix

A

most are -mab

25
Q

Non-TNF-a Biologics for RA

A

rituximab
abatacept
tocilizumab
baricitinib
anakinra
block different interleukins, kinases, tcells, b cells

26
Q

PT considerations for pts on DMARDs

A

reduced immune response
fatigue/reduced exercise tolerance
injection site reactions
increased risk of fracture
analgesic use